YM17E
Chimonanthine
Yohimbic acid
Xylose
alpha-D-glucose
α-L-Rhamnose monohydrate
Xylotriose
Limocitrin
4-O-Methylepisappanol
2-Methylsuccinic acid
Taxifolin 7-O-rhamnoside
4'-Hydroxychalcone
Phloretin
Corylin
Dihydrorotenone
3',4'-O,O-Methylene-(+)-catechin
6-Formyl-isoophiopogonanone A
Melanin
Aucubin
Picroside II
Loganic acid
Micheliolide
Homatropine Methylbromide
Damnacanthol
Physcion
Etomoxir
4-Methylumbelliferone
Pinoresinol diglucoside
Anthriscinol
Piscerygenin
L-Arginine(L-glutamate)
DL-Methionine
L-Asparagine monohydrate
Irinotecan-d10
Irinotecan-d10 hydrochloride
Gepotidacin S enantiomer
VU0155069
Avizakimab
Nadunolimab
LEESGGGLVQPGGSMK acetate
Lacnotuzumab
Anti-Mouse IL-1a Antibody
Etaracizumab
Torcetrapib
Anti-MERS-3A1 mAb
Ogalvibart
Firivumab
Perakizumab
Afasevikumab
Quilizumab
Amatuximab
Rontalizumab
Peldesine dihydrochloride
Z-Asp-CH2-DCB
Influenza Matrix Protein(61-72)
Neihulizumab
Caerulomycin A
GABAA receptor agent 4
Phytosphingosine
IC 86621
